122 related articles for article (PubMed ID: 14556896)
21. Molecular dynamics and binding specificity analysis of the bovine immunodeficiency virus BIV Tat-TAR complex.
Reyes CM; Nifosì R; Frankel AD; Kollman PA
Biophys J; 2001 Jun; 80(6):2833-42. PubMed ID: 11371457
[TBL] [Abstract][Full Text] [Related]
22. Interaction of HIV RNA with peptides detected by acoustic shear wave sensor operated in an on-line format.
Deisingh AK; Siewah S; Tassew N; Thompson M
Methods Mol Biol; 2007; 385():205-14. PubMed ID: 18365714
[TBL] [Abstract][Full Text] [Related]
23. Probing Tat peptide-TAR RNA interactions by psoralen photo-cross-linking.
Wang Z; Shah K; Rana TM
Biochemistry; 2001 May; 40(21):6458-64. PubMed ID: 11371209
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
[TBL] [Abstract][Full Text] [Related]
25. The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
Metzger AU; Bayer P; Willbold D; Hoffmann S; Frank RW; Goody RS; Rösch P
Biochem Biophys Res Commun; 1997 Dec; 241(1):31-6. PubMed ID: 9405229
[TBL] [Abstract][Full Text] [Related]
26. The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction.
Chaloin O; Peter JC; Briand JP; Masquida B; Desgranges C; Muller S; Hoebeke J
Cell Mol Life Sci; 2005 Feb; 62(3):355-61. PubMed ID: 15723170
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
28. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
29. Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.
Olsen GL; Edwards TE; Deka P; Varani G; Sigurdsson ST; Drobny GP
Nucleic Acids Res; 2005; 33(11):3447-54. PubMed ID: 15961729
[TBL] [Abstract][Full Text] [Related]
30. RNA binding by the tat and rev proteins of HIV-1.
Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 Tat protein is able to efficiently transactivate the HIV-2 LTR through a TAR RNA element lacking both dinucleotide bulge binding sites.
Rhim H; Rice AP
Virology; 1995 Jan; 206(1):673-8. PubMed ID: 7831824
[TBL] [Abstract][Full Text] [Related]
32. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
Aboul-ela F; Karn J; Varani G
J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
[TBL] [Abstract][Full Text] [Related]
33. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
Calnan BJ; Biancalana S; Hudson D; Frankel AD
Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
[TBL] [Abstract][Full Text] [Related]
34. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
Faber C; Sticht H; Schweimer K; Rösch P
J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
[TBL] [Abstract][Full Text] [Related]
35. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate.
Hamma T; Saleh A; Huq I; Rana TM; Miller PS
Bioorg Med Chem Lett; 2003 Jun; 13(11):1845-8. PubMed ID: 12749881
[TBL] [Abstract][Full Text] [Related]
37. Dual-specificity interaction of HIV-1 TAR RNA with Tat peptide-oligonucleotide conjugates.
Tung CH; Wang J; Leibowitz MJ; Stein S
Bioconjug Chem; 1995; 6(3):292-5. PubMed ID: 7632801
[TBL] [Abstract][Full Text] [Related]
38. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
Smith CA; Crotty S; Harada Y; Frankel AD
Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
[TBL] [Abstract][Full Text] [Related]
39. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
